Ann: INV103 ala-Cpn10 clinical trial in lupus complete, page-5

  1. 1,206 Posts.
    lightbulb Created with Sketch. 116
    Agree, but nevertheless very impressive decreases in Cytokines. Make no mistake, this drug works.
    No mention of nephritis? The trial remains open, I can only presume those recruited for the 5th cohort have more serious kidney disorders? I would like to hear something from the company because this is the area of unmet need.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
9.6¢
Change
0.000(0.00%)
Mkt cap ! $8.199M
Open High Low Value Volume
9.6¢ 9.8¢ 9.6¢ $3.656K 38.07K

Buyers (Bids)

No. Vol. Price($)
2 20756 9.6¢
 

Sellers (Offers)

Price($) Vol. No.
9.9¢ 146502 2
View Market Depth
Last trade - 15.11pm 07/08/2025 (20 minute delay) ?
IVX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.